Finance

Lists
Why is 424870 down 5,56%?
Dive Deeper
424870:KOSDAQ
ImmuneOncia Therapeutics Inc
2 380,00 ₩
-5,56%
(-140,00) 1D
6 նոյ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 424870...
Open
2 350 ₩
High
2 470 ₩
Low
2 330 ₩
Mkt. cap
217,54 մլրդ
Avg. vol.
781,12 հզր
Volume
0,00
52-wk high
14 964 ₩
52-wk low
2 300 ₩
EPS
-380 ₩
Shares outstanding
91,40 մլն
No. of employees
26
Open
2 350 ₩
High
2 470 ₩
Low
2 330 ₩
Mkt. cap
217,54 մլրդ
Avg. vol.
781,12 հզր
Volume
0,00
52-wk high
14 964 ₩
52-wk low
2 300 ₩
EPS
-380 ₩
Shares outstanding
91,40 մլն
No. of employees
26
News stories
From web sources and news partners
About ImmuneOncia Therapeutics Inc
CEO-
Employees26
Founded2016
Headquarters-
SectorHealth Care
Industry-
Websiteimmuneoncia.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
4,07 մլն
2,88 մլն
3,50 մլն
3,94 մլն
Cost of revenue
4,07 մլն
2,88 մլն
3,50 մլն
3,94 մլն
Research and development expenses
9,29 մլրդ
8,31 մլրդ
4,51 մլրդ
2,85 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,11 մլրդ
1,06 մլրդ
1,04 մլրդ
1,24 մլրդ
Operating expense
10,59 մլրդ
9,56 մլրդ
5,75 մլրդ
4,27 մլրդ
Total operating expenses
10,60 մլրդ
9,57 մլրդ
5,75 մլրդ
4,27 մլրդ
Operating income
-10,60 մլրդ
-9,57 մլրդ
-5,75 մլրդ
-4,27 մլրդ
Other non operating income
-35,53 մլն
-15,34 մլն
-807,92 հզր
-1,09 մլն
EBT including unusual items
-10,37 մլրդ
-9,41 մլրդ
-5,62 մլրդ
-3,90 մլրդ
EBT excluding unusual items
-10,37 մլրդ
-9,41 մլրդ
-5,62 մլրդ
-3,90 մլրդ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2,54 մլն
6,36 մլն
17,97 մլն
4,66 մլն
Net income
-10,37 մլրդ
-9,41 մլրդ
-5,62 մլրդ
-3,90 մլրդ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
245,26 մլն
206,69 մլն
162,59 մլն
416,30 մլն
Interest expense
-1,28 մլն
-1,21 մլն
-995,00 հզր
-779,00 հզր
Net interest expenses
243,97 մլն
205,48 մլն
161,60 մլն
415,52 մլն
Depreciation and amortization charges
40,98 մլն
40,33 մլն
38,52 մլն
37,32 մլն
EBITDA
-10,33 մլրդ
-9,34 մլրդ
-5,53 մլրդ
-4,06 մլրդ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps